October 8, 2025
Lise Bertrand, Scientific Director of Digital Pathology at Charles River Laboratories and Jogile Kuklyte, Senior Product Manager, AI at Patholytix will walk through real-world workflows step by step, showing how Foresight 2.0 streamlines safety studies without compromising scientific rigor.
Join us for this 30-minute webinar where we take you inside the day of a toxicologic pathologist working with AI. Lise Bertrand, Scientific Director of Digital Pathology at Charles River Laboratories and Jogile Kuklyte, Senior Product Manager, AI at Patholytix will walk through real-world workflows step by step, showing how Foresight 2.0 streamlines safety studies without compromising scientific rigor.
Through live demonstrations and shared best practices, our speakers will highlight how AI can be seamlessly integrated into routine drug safety assessments. You’ll see exactly where efficiency gains are realized, how quality is maintained, and how pathologists can confidently harness AI to optimize their reviews.
This session will conclude with a discussion on lessons learned from early adopters, offering practical guidance for applying Foresight 2.0 in your own studies.
Don’t miss this opportunity to experience the future of toxicologic pathology workflows in action.
When
October 23 2025 at 2PM GMT +1
Click here to register
Speakers
Lise Bertrand, Scientific Director of Digital Pathology at Charles River Laboratories and Jogile Kuklyte, Senior Product Manager, AI at Patholytix will walk through real-world workflows step by step, showing how Foresight 2.0 streamlines safety studies without compromising scientific rigor.
Join us for this 30-minute webinar where we take you inside the day of a toxicologic pathologist working with AI. Lise Bertrand, Scientific Director of Digital Pathology at Charles River Laboratories and Jogile Kuklyte, Senior Product Manager, AI at Patholytix will walk through real-world workflows step by step, showing how Foresight 2.0 streamlines safety studies without compromising scientific rigor.
Through live demonstrations and shared best practices, our speakers will highlight how AI can be seamlessly integrated into routine drug safety assessments. You’ll see exactly where efficiency gains are realized, how quality is maintained, and how pathologists can confidently harness AI to optimize their reviews.
This session will conclude with a discussion on lessons learned from early adopters, offering practical guidance for applying Foresight 2.0 in your own studies.
Don’t miss this opportunity to experience the future of toxicologic pathology workflows in action.
When
October 23 2025 at 2PM GMT +1
Click here to register
Speakers
Follow us
Ireland
DCU Alpha Building, Innovation Campus,
11 Old Finglas Rd, Glasnevin, Co. Dublin D11 KXN4
